摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-Methyl-2-(2,4,6-trimethylphenyl)imidazo[1,5-a]pyridinium | 849797-80-4

中文名称
——
中文别名
——
英文名称
5-Methyl-2-(2,4,6-trimethylphenyl)imidazo[1,5-a]pyridinium
英文别名
5-methyl-2-(2,4,6-trimethylphenyl)imidazo[1,5-a]pyridin-2-ium
5-Methyl-2-(2,4,6-trimethylphenyl)imidazo[1,5-a]pyridinium化学式
CAS
849797-80-4
化学式
C17H19N2+
mdl
——
分子量
251.35
InChiKey
OFTYWHDNJVHNDO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.1
  • 重原子数:
    19
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    8.3
  • 氢给体数:
    0
  • 氢受体数:
    0

文献信息

  • HYDROSILYLATION IRON CATALYST
    申请人:KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
    公开号:US20170260216A1
    公开(公告)日:2017-09-14
    A hydrosilylation iron catalyst prepared from a two-electron ligand (L) and a mononuclear, binuclear, or trinuclear complex of iron indicated by formula (1), Fe having bonds with carbon atoms included in X and the total number of Fe-carbon bonds being 2-10. As a result of using iron, the hydrosilylation iron catalyst is advantageous from a cost perspective as well as being easily synthesized. Hydrosilylation reactions can be promoted under mild conditions by using this catalyst. Fe(X) a (1) (in the formula, each X independently indicates a C2-30 ligand that may include an unsaturated group excluding carbonyl groups (CO groups) and cyclopentadienyl groups, however at least one X includes an unsaturated group, a indicates an integer of 2-4 per Fe atom.)
    使用双电子配体(L)和由公式(1)表示的的单核、双核或三核配合物制备的硅化铁催化剂,其中Fe与X中包含的碳原子形成键,Fe-碳键的总数为2-10。由于使用硅化铁催化剂从成本角度来看具有优势,同时也易于合成。通过使用这种催化剂,可以在温和条件下促进化反应。在公式中,每个X独立地表示一个可能包括除羰基(CO基团)和环戊二烯基团以外的不饱和基团的C2-30配体,然而至少有一个X包括不饱和基团,a表示每个原子2-4的整数。)
  • HYDROSILYLATION REACTION CATALYST
    申请人:KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
    公开号:US20170260215A1
    公开(公告)日:2017-09-14
    A hydrosilylation reaction catalyst prepared from: a catalyst precursor comprising a transition metal compound, excluding platinum, belonging to group 8-10 of the periodic table, e.g., iron acetate, cobalt acetate, nickel acetate, etc.; and a ligand comprising a carbine compound such as 1,3-dimesitylimidazol-2-ylidene, etc. The hydrosilylation reaction catalyst has excellent handling and storage properties. As a result of using this catalyst, a hydrosilylation reaction can be promoted under gentle conditions.
    一种硅烷基化反应催化剂的制备方法:包括过渡属化合物的催化剂前体,不包括,属于周期表8-10族的过渡属,例如,醋酸铁醋酸醋酸镍等;以及包括碳氢化合物的配体,例如1,3-二间苯基咪唑-2-基亚胺等。该硅烷基化反应催化剂具有优异的搅拌和储存性能。使用该催化剂可以在温和条件下促进硅烷基化反应。
  • Method for treating neurological disorders with imidazolium and imidazolinium compounds
    申请人:Agency for Science, Technology and Research
    公开号:EP2803356A1
    公开(公告)日:2014-11-19
    There is presently provided methods for delivering a neuroprotective agent to a neural cell. The methods comprise contacting a neural cell with an imidazolium or imidazolinium compound as described herein, including an imidazolium or imidazolinium salt.
    目前提供了向神经细胞递送神经保护剂的方法。这些方法包括将神经细胞与本文所述的咪唑咪唑啉化合物(包括咪唑盐或咪唑啉盐)接触。
  • Hydrosilylation reaction catalyst
    申请人:KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
    公开号:US10000515B2
    公开(公告)日:2018-06-19
    A hydrosilylation reaction catalyst prepared from: a catalyst precursor comprising a transition metal compound, excluding platinum, belonging to group 8-10 of the periodic table, e.g., iron acetate, cobalt acetate, nickel acetate, etc.; and a ligand comprising a carbine compound such as 1,3-dimesitylimidazol-2-ylidene, etc.. The hydrosilylation reaction catalyst has excellent handling and storage properties. As a result of using this catalyst, a hydrosilylation reaction can be promoted under gentle conditions.
    一种加氢硅烷化反应催化剂,由以下物质制备而成:催化剂前体,包括属于元素周期表第 8-10 族的过渡属化合物(除外),如醋酸铁醋酸醋酸镍等;配体,包括碳化合物,如 1,3-二甲基咪唑-2-亚基等。这种氢硅烷化反应催化剂具有极佳的处理和储存性能。使用这种催化剂,可以在温和的条件下促进硅烷化反应。
  • METHOD FOR TREATING NEUROLOGICAL DISORDERS WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS
    申请人:Zhuo Lang
    公开号:US20110028513A1
    公开(公告)日:2011-02-03
    There is presently provided methods for delivering a neuroprotective agent to a neural cell. The methods comprise contacting a neural cell with an imidazolium or imidazolinium compound as described herein, including an imidazolium or imidazolinium salt.
查看更多